Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD

NCT02321241 · clinicaltrials.gov ↗

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Wet Macular Degeneration

Interventions

DRUG: Aflibercept (EYLEA, BAY-86-5321)

Sponsor

Bayer

Collaborators

[object Object]